BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1930283)

  • 1. The effect of vindesine on methotrexate hydroxylation in the rat.
    Bremnes RM; Smeland E; Slørdal L; Wist E; Aarbakke J
    Biochem Pharmacol; 1991 Sep; 42(8):1561-8. PubMed ID: 1930283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of 7-hydroxymethotrexate formation by amsacrine.
    Bremnes RM; Smeland E; Willassen NP; Wist E; Aarbakke J
    Cancer Chemother Pharmacol; 1991; 28(5):377-83. PubMed ID: 1914082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of vinblastine and vincristine with methotrexate transport in isolated rat hepatocytes.
    Smeland E; Bremnes RM; Bessesen A; Jaeger R; Aarbakke J
    Cancer Chemother Pharmacol; 1993; 32(3):209-14. PubMed ID: 8500226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-vindesine association in head and neck cancer: modification of methotrexate's hydroxylation in presence of vindesine.
    Bore P; Lena N; Imbert AM; Favre R; Cano JP; Meyer G; Carcassonne Y
    Cancer Chemother Pharmacol; 1986; 17(2):171-6. PubMed ID: 3719898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent pharmacokinetics of methotrexate and 7-hydroxymethotrexate in the rat in vivo.
    Bremnes RM; Slørdal L; Wist E; Aarbakke J
    Cancer Res; 1989 Nov; 49(22):6359-64. PubMed ID: 2804982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation and elimination of 7-hydroxymethotrexate in the rat in vivo after methotrexate administration.
    Bremnes RM; Slørdal L; Wist E; Aarbakke J
    Cancer Res; 1989 May; 49(9):2460-4. PubMed ID: 2706634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo-in vitro relationship of methotrexate 7-hydroxylation by aldehyde oxidase in four different strain rats.
    Moriyasu A; Sugihara K; Nakatani K; Ohta S; Kitamura S
    Drug Metab Pharmacokinet; 2006 Dec; 21(6):485-91. PubMed ID: 17220564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3.
    Huang C; Xia F; Xue L; Liu L; Bian Y; Jin Z; Miao L
    Cancer Chemother Pharmacol; 2020 Feb; 85(2):433-441. PubMed ID: 31691080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hepatotoxicity after high-dose methotrexate administration to rats.
    Bremnes RM; Smeland E; Huseby NE; Eide TJ; Aarbakke J
    Pharmacol Toxicol; 1991 Aug; 69(2):132-9. PubMed ID: 1775433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of methotrexate (MTX) and 7-hydroxymethotrexate (7-OH-MTX) in rats and evidence for the metabolism of MTX to 7-OH-MTX.
    Fahrig L; Brasch H; Iven H
    Cancer Chemother Pharmacol; 1989; 23(3):156-60. PubMed ID: 2924373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between 7-hydroxymethotrexate and folinic acid in RAJI cells, in vitro.
    Payet B; Fabre I; Fabre G; Cano JP
    Cancer Lett; 1988 Feb; 39(1):45-58. PubMed ID: 3257895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate-vindesine association in leukemia: pharmacokinetic study.
    Tubiana N; Lena N; Barbet J; Imbert AM; Lejeune C; Maraninchi D; Sainty D; Sebahoun G; Gastaut JA; Cano JP
    Med Oncol Tumor Pharmacother; 1985; 2(2):99-102. PubMed ID: 3864001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perturbation of methotrexate transport by verapamil, vinblastine, taurocholate and bromosulfophthalein in rat hepatocytes.
    Smeland E; Bremnes RM; Fuskevåg OM; Aarbakke J
    Anticancer Res; 1995; 15(1):45-50. PubMed ID: 7733639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro pharmacokinetics and metabolism of vincaalkaloids in rat. I. Vindesine (4-deacetyl-vinblastine 3-carboxyamide).
    Rahmani R; Zhou XJ; Placidi M; Martin M; Cano JP
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):49-55. PubMed ID: 2384117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No influence of enzyme inhibitors on the hydroxylation of methotrexate in rats.
    Yu D; Brasch H; Iven H
    Cancer Lett; 1989 Nov; 48(2):153-6. PubMed ID: 2819703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate-vindesine association in the treatment of head and neck cancer influence of vindesine on methotrexate's pharmacokinetic behavior.
    Lena N; Imbert AM; Pignon T; Favre R; Meyer G; Cano JP; Carcassonne Y
    Cancer Chemother Pharmacol; 1984; 12(2):120-4. PubMed ID: 6697425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between 7-hydroxymethotrexate and methotrexate at the cellular level in the Ehrlich ascites tumor in vitro.
    Fabre G; Matherly LH; Fabre I; Cano JP; Goldman ID
    Cancer Res; 1984 Mar; 44(3):970-5. PubMed ID: 6692419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of depletion of cellular glutathione on methotrexate influx, efflux and retention in hepatocytes.
    Leszczyńska-Bisswanger A; Pfaff E
    Biochem Pharmacol; 1985 May; 34(10):1627-34. PubMed ID: 2408621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal and hepatic toxicity after high-dose 7-hydroxymethotrexate in the rat.
    Smeland E; Bremnes RM; Andersen A; Jaeger R; Eide TJ; Huseby NE; Aarbakke J
    Cancer Chemother Pharmacol; 1994; 34(2):119-24. PubMed ID: 8194163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in methotrexate pharmacokinetics by naproxen in the rat as measured by microdialysis.
    Ekstrøm PO; Giercksky KE; Andersen A; Slørdal L
    Life Sci; 1997; 60(24):PL 359-64. PubMed ID: 9188769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.